Topics

NHS England Teams with Gilead, Merck and AbbVie to Eliminate Hepatitis C

20:00 EDT 29 Apr 2019 | BioSpace

NHS England will acquire hepatitis C drugs from the companies at competitive prices and work to identify patients around the country.

Original Article: NHS England Teams with Gilead, Merck and AbbVie to Eliminate Hepatitis C

NEXT ARTICLE

More From BioPortfolio on "NHS England Teams with Gilead, Merck and AbbVie to Eliminate Hepatitis C"

Quick Search

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...